Department of Neurology, Faculty of Medicine, Alanya Alaaddin Keykubat University, Antalya/Alanya, Turkey
Istanbul Medipol University, Regenerative and Restorative Medicine Research Center, Istanbul, Turkey
Curr Clin Pharmacol. 2020;15(2):105-109. doi: 10.2174/1574884714666190226093119.
Antibiotic therapies targeting multiple regenerative mechanisms have the potential for neuroprotective effects, but the diversity of experimental strategies and analyses of non-standardised therapeutic trials are challenging. In this respect, there are no cases of successful clinical application of such candidate molecules when it comes to human patients.
After 24 hours of culturing, three different minocycline (Sigma-Aldrich, M9511, Germany) concentrations (1 μM, 10 μM and 100 μM) were added to the primary cortical neurons 15 minutes before laser axotomy procedure in order to observe protective effect of minocycline in these dosages.
Here, we have shown that minocycline exerted a significant neuroprotective effect at 1 and 100μM doses. Beyond confirming the neuroprotective effect of minocycline in a more standardised and advanced in-vitro trauma model, our findings could have important implications for future studies that concentrate on the translational block between animal and human studies.
Such sophisticated approaches might also help to conquer the influence of humanmade variabilities in critical experimental injury models. To the best of our knowledge, this is the first study showing that minocycline increases in-vitro neuronal cell survival after laser-axotomy.
针对多种再生机制的抗生素疗法具有神经保护作用的潜力,但实验策略的多样性和非标准化治疗试验的分析具有挑战性。在这方面,当涉及到人类患者时,还没有成功将此类候选分子应用于临床的案例。
在培养 24 小时后,三种不同浓度的米诺环素(Sigma-Aldrich,M9511,德国)(1 μM、10 μM 和 100 μM)在激光轴突切断术前 15 分钟添加到原代皮质神经元中,以观察米诺环素在这些剂量下的保护作用。
在这里,我们表明米诺环素在 1 和 100μM 剂量下表现出显著的神经保护作用。除了在更标准化和先进的体外创伤模型中证实米诺环素的神经保护作用外,我们的发现对于集中研究动物和人类研究之间的转化障碍的未来研究可能具有重要意义。
这种复杂的方法还可能有助于克服关键实验损伤模型中人为变异的影响。据我们所知,这是第一项表明米诺环素增加激光轴突切断后体外神经元细胞存活的研究。